Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells

被引:30
|
作者
Andreasson, Ulrika [1 ,2 ]
Dictor, Michael [3 ]
Jerkeman, Mats [2 ,4 ]
Berglund, Mattias [5 ]
Sundstrom, Christer [6 ,7 ]
Linderoth, Johan [4 ]
Rosenquist, Richard [6 ,7 ]
Borrebaeck, Carl A. K. [1 ,2 ]
Ek, Sara [1 ,2 ]
机构
[1] Lund Univ, Dept Immunotechnol, Lund, Sweden
[2] Lund Univ, CREATE Hlth, Lund, Sweden
[3] Univ Lund Hosp, Dept Pathol, S-22184 Lund, Sweden
[4] Univ Lund Hosp, Dept Oncol, S-22184 Lund, Sweden
[5] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[6] Uppsala Univ, Dept Genet, Uppsala, Sweden
[7] Uppsala Univ, Dept Pathol, Uppsala, Sweden
关键词
NON-HODGKINS-LYMPHOMAS; HIGHER GRADE TRANSFORMATION; FOLLICLE CENTER LYMPHOMA; GENE-EXPRESSION; KAPPA-B; GALECTIN-3; PATTERNS; SURVIVAL; MICROENVIRONMENT; PROGRESSION;
D O I
10.1002/ajh.21549
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Follicular lymphoma (FL) frequently transforms into the more aggressive diffuse large B cell lymphoma (DLBCL-tr), but no protein biomarkers have been identified for predictive or early diagnosis. Gene expression analyses have identified genes changing on transformation but have failed to be reproducible in different studies, reflecting the heterogeneity within the tumor tissue and between tumor samples. Gene expression analyses on Affymetrix Human Genome U133 Plus 2.0 arrays were performed, using flow cytometry sorted tumor cells derived from FL and transformed DLBCL. To identify molecular targets associated with the transformation, subsequent immunohistochemistry (IHC) analyses of the corresponding proteins were performed. Using highly purified cells, this study identified 163 genes, which were significantly deregulated during the transformation in a majority of cases. Among the upregulated transcripts, 13 genes were selected for validation using IHC, based on the availability of commercial antibodies, and galectin-3 and NEK2 proteins specifically identify DLBCL-tr, when compared with FL. We demonstrate that by purifying tumor cells through cell sorting, thereby reducing the heterogeneity due to infiltrating cells, it was possible to identify distinct differences between tumor entities rather than variations due to cellular composition. Galectin-3 and NEK2 both identified a subgroup of DLBCL-tr, and the function of these protein markers also suggests a biological role in the transformation process. Am. J. Hematol. 84:803-808, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:803 / 808
页数:6
相关论文
共 50 条
  • [21] Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva
    Harada, Naonori
    Tagami, Mizuki
    Koh, Hideo
    Ohsawa, Masahiko
    Hino, Masayuki
    Nakamae, Hirohisa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (04) : 413 - 414
  • [22] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
  • [23] Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva
    Naonori Harada
    Mizuki Tagami
    Hideo Koh
    Masahiko Ohsawa
    Masayuki Hino
    Hirohisa Nakamae
    International Journal of Hematology, 2021, 114 : 413 - 414
  • [24] Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL)
    Heini, Alexander D.
    Bacher, Ulrike
    Pabst, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (02) : 389 - 390
  • [25] Identification and Characterization of a B Cell Aptamer That Targets Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Myelogenous Leukemia (CML)
    Pratico, Elizabeth D.
    Nair, Smita K.
    Sullenger, Bruce A.
    MOLECULAR THERAPY, 2015, 23 : S29 - S29
  • [26] Molecular pathogenesis of diffuse large B-cell lymphoma
    Schneider, Christof
    Pasqualucci, Laura
    Dalla-Favera, Riccardo
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2011, 28 (02) : 167 - 177
  • [27] Molecular Classification of Diffuse Large B-Cell Lymphoma
    Baa, Annie Kanchan
    Rasheed, Azgar Abdul
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 356 - 359
  • [28] Diffuse large B cell lymphoma: molecular targeted therapy
    Roschewski, Mark
    Dunleavy, Kieron
    Wilson, Wyndham H.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 552 - 561
  • [29] Molecular pathogenesis of diffuse large B-cell lymphoma
    Lossos, IS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) : 6351 - 6357
  • [30] The molecular biology of diffuse large B-cell lymphoma
    Frick, Mareike
    Doerken, Bernd
    Lenz, Georg
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (06) : 369 - 379